NAUTILUS BIOTECHNOLOGY INC (NAUT) Stock Income Statement
NASDAQ:NAUT - Nasdaq - US63909J1088 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 81.48M | 76.15M | 63.62M | 50.50M | 15.74M | |||
| Research and Development | 48.48M | 45.45M | 36.47M | 28.35M | 12.43M | |||
| Selling, General, and Administrative Expenses | 31.00M | 28.90M | 25.95M | 21.15M | 3.31M | |||
| Operating Income | -81.48M | -76.15M | -63.62M | -50.50M | -15.74M | |||
| Interest Income/Expense | 10.78M | 12.55M | 5.82M | N/A | 50.00K | |||
| Other Income/Expense | -84.00K | -73.00K | -120.00K | 180.00K | 130.00K | |||
| Income Before Taxes | -70.78M | -63.67M | -57.92M | -50.32M | -15.62M | |||
| Net Income | -70.78M | -63.67M | -57.92M | -50.32M | -15.62M | |||
| EBITDA | -79.50M | -74.30M | -62.40M | -49.48M | -15.03M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.56 | -0.51 | -0.46 | -0.40 | -0.13 | |||
| Non GAAP EPS | -0.56 | -0.52 | -0.47 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD